Chemotaxis/migration of immune cells
|
Pf4/Cxcl4
|
60633 ± 8047 |
Platelet factor 4 (PF4), promoting coagulation, chemotactic for neutrophils and fibroblasts. Role in monocyte activation31
|
Ccl4
|
23470 ± 492 |
Macrophage inflammatory protein 1β (MIP-1β), chemotactic for monocytes32 and T-cell33
|
Itgb2
|
18959 ± 1385 |
Integrin beta-2 (CD18), Leukocyte adhesion |
Ccl12
|
14047 ± 596 |
Monocyte chemotactic protein-5 (MCP-5), attracts eosinophils, monocytes and lymphocytes |
Ccr5
|
9960 ± 1401 |
Receptor for CCL4/CCL5. CCR5 oligomerizes with CCR2 and CXCR434. |
Ccr1
|
5939 ± 568 |
Receptor for CCL5, recruitment of effector immune cells. |
Itgam
|
4270 ± 332 |
CD11b, Macrophage-1 antigen, regulating leukocyte adhesion and migration. |
Ccl3
|
465 ± 12 |
Macrophage inflammatory protein 1α (MIP-1α), Interact with CCL435. Attracts macrophages, monocytes and neutrophils. |
Cxcl12
|
366 ± 45 |
Stromal cell-derived factor 1 (SDF-1), chemotactic for lymphocytes36; Binds CXCR4, important for homing of MSCs to the injured site37. |
Ccr2
|
149 ± 48 |
CD192, Receptor for CCL2 (MCP-1), Important for MSC homing38, 39, and monocyte recruitment40
|
Ccl2
|
78 ± 7 |
Monocyte chemotactic protein-1 (MCP-1), mediating monocyte chemotaxis signalling through CCR2. |
Ccl11
|
12 ± 1 |
CCL11 heterodimerizes with CCL241
|
Ccl5
|
10 ± 1 |
RANTES, CCR5 ligand, role in peripheral opioid expression42. |
Antiinflammatory cytokines/receptors
|
Il10ra
|
1034 ± 78 |
IL-10 receptor subunit alpha. |
Il10
|
4 ± 0.4 |
Role in BMSC’s anti-sepsis effect22. |
IL-13RA1
|
3 ± 0.2 |
IL-13 receptor, alpha 1. |
Tgfb (TGFβ) |
2 ± 0.1 |
Role in BMSC’s antihyperalgesia4. |
Proinflammatory cytokines/receptors
|
Tnf
|
5019 ± 534 |
Also stimulate MOR gene expression in neurons43. |
Il1b
|
1438 ± 149 |
Important mediator of inflammatory response. |
Il18
|
1104 ± 61 |
Inducing interferon-gamma, which leads to activation of macrophage. |
Tnfrsf1b
|
8 ± 1 |
TNFR2, CD120b, receptor for TNF. |
Casp1
|
36 ± 2 |
Caspase 1, Cleavage of precursors of the inflammatory cytokines IL-1β and IL-18. |
C3
|
1501 ± 74 |
Complement component 3, related to BMSC activity21. |
C5
|
26 ± 2 |
Complement component 5, related to BMSC activity21. |
Regulation of opioids
|
Cxcl5
|
793 ± 29 |
LIX, CXCR2 ligand, LPS-induced chemokine, neutrophil-activating peptide 78 (ENA-78). |
Cxcl2
|
316 ± 59 |
MIP-2α, CXCR2 ligand, chemotactic for polymorphonuclear leukocytes. |
Cxcr2/Il8rb
|
15 ± 1 |
Receptor for CXCL1/CXCL2, involved in opioid release from polymorphonuclear leukocytes30. |
Cxcl1
|
3 ± 0.3 |
CXCR2 ligand; Related to opioid release from polymorphonuclear leukocytes44. |